SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-23-015000
Filing Date
2023-07-18
Accepted
2023-07-18 16:37:14
Documents
2
Period of Report
2023-07-14

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3839
2 POWER OF ATTORNEY exhibit24.htm EX-24 10400
  Complete submission text file 0001062993-23-015000.txt   15666
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 303 SOUTH BROADWAY SUITE 125 TARRYTOWN NY 10591
Business Address
Derby Michael (Reporting) CIK: 0001809613 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35776 | Film No.: 231094736